Roger R. Gomis
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Economic impact of MAF testing for adjuvant bisphosphonate therapy in early breast cancer: a multi-regional budget impact analysis from a payer perspective.
Journal: Journal of medical economics
Published: August 02, 2025
Sphingosine-1-Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere Proliferation and Metastasis.
Sphingosine-1-Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere Proliferation and Metastasis.
Journal: International journal of cancer
Published: July 28, 2025
Correction: The PP2A regulator IER5L supports prostate cancer progression.
Journal: Cell death & disease
Published: July 22, 2025
A bioinformatics screen identifies TCF19 as an aggressiveness-sustaining gene in prostate cancer.
Journal: Molecular oncology
Published: April 16, 2025
Transcriptional analysis of metastatic hormone-naïve prostate cancer primary tumor biopsies reveals a relevant role for SOX11 in prostate cancer cell dissemination.
Journal: Genome biology
Published: August 07, 2024
Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression.
Journal: Nature communications
Published: March 25, 2024
The PP2A regulator IER5L supports prostate cancer progression.
Journal: Cell death & disease
Published: December 21, 2023
MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis.
Journal: Nature cell biology
Published: September 16, 2022
Design and optimization of oestrogen receptor PROTACs based on 4-hydroxytamoxifen.
Journal: European journal of medicinal chemistry
Published: June 01, 2022
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy.
Journal: Nature communications
Published: January 25, 2022
Last Updated: 09/26/2026